Integrated Genomics and Avatar Mouse Models for Personalized Treatment of Pancreatic Cancer

Registry ID

EUCTR2015-004860-12

Source registry

EUCTR

Status

Ongoing

Phase

PHASE3

Sponsor

Centro Nacional Investigaciones Oncológicas (CNIO)

Start date

2016-02-24

Last update

2026-08-16

Conditions

• Metastatic pancreatic cancer

Summary

To compare the efficacy of implementing an integrated genetics and avatar mouse model personalized treatment strategy to the conventional treatment strategy in patients with metastatic PDAC

Locations

• , , Spain

Related clinical trials

• PRODIGE 61- FFCD 1702 - FUNGEMAX Randomized phase II study comparing 5FU/LV+Nal-IRI, gemcitabine+Nab-paclitaxel or a sequential regimen of 2 months 5FU/LV+Nal-IRI followed by two months of gemcitabine+Nab-paclitaxel, in metastatic pancreatic cancer

View on source registry